Press release
InShapeMD Launches Limited-Time 50% Discount on Insulin Resistance Testing to Help Individuals Detect Hidden Health Risks Early
The San Angelo-based medical weight loss clinic aims to help patients uncover silent metabolic issues, such as insulin resistance, that may be blocking their progress.San Angelo, Texas, 11th June 2025, ZEX PR WIRE, InShapeMD, a medical weight loss clinic in San Angelo, Texas, has launched a limited-time initiative to make early detection of metabolic issues more accessible. The clinic now offers a 50% discount on its specialized Insulin Resistance Test (Cardio IQ Insulin Resistance Panel) for patients who schedule a consultation.
This diagnostic offer is part of the clinic's broader push to help individuals uncover hidden health risks-especially when standard diets and exercise plans fail to deliver expected results. Chronic inflammation, insulin resistance, and metabolic imbalance are often undetected contributors to stubborn weight gain and fatigue, yet they're rarely tested for in routine checkups.
"You don't have to be diabetic to struggle with blood sugar regulation," said a spokesperson for InShapeMD."We see patients all the time who are doing everything right-eating clean, exercising, sleeping well-but still feel stuck. Testing for insulin resistance reveals what's going on beneath the surface. From there, we can personalize treatments like peptide therapy or nutritional interventions that actually work with the body instead of against it."
The Insulin Resistance Test (Cardio IQ Panel) provides advanced insights into glucose metabolism and insulin function, serving as a foundation for customized treatment planning. InShapeMD's approach doesn't stop at lab results; the clinic offers medical tools designed to reverse metabolic disruption and lower chronic inflammation.
For example, patients diagnosed with insulin resistance may be guided toward InShapeMD's weight loss peptide service, which includes therapies that support fat metabolism, muscle preservation, and appetite regulation.
Additionally, vitamin B12 shots are used to combat fatigue and improve metabolic function at a cellular level. These services often complement the clinic's broader metabolic programs, such as the Low T Program in San Angelo for men experiencing hormone-related weight changes.
Studies have shown that chronic low-grade inflammation and insulin resistance are linked to abdominal fat retention, energy crashes, and increased risk of type 2 diabetes. Yet many people continue to focus on surface-level solutions without addressing the root cause. That's what makes this initiative different-it reframes weight struggles through a medical lens.
The offer is available for a limited time and includes a discounted lab panel followed by a consultation with InShapeMD's team to interpret results and build a personalized care plan.
"At the end of the day, we want to take the guesswork out of weight loss," the spokesperson added. "This test helps us do that-and gives our patients the clarity they've been missing."
Interested individuals can contact the clinic using the information provided below for more information about the 50% discounted test or to book a consultation.
Contact Information
Website: www.inshapemdtx.com
Phone: (325) 227-4981
Address: 3270 Sherwood Way, San Angelo, TX 76901
Hours: Mon-Thur 8 am-5 pm, Fri 8 am-12 pm
Patient Forms
About InShapeMD
InShapeMD is a medical weight loss clinic in San Angelo, Texas, offering lab-based metabolic assessments, hormone therapy, peptide support, NAD+ treatment, and customized weight loss plans. The clinic specializes in addressing the root causes of weight gain for long-term wellness.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release InShapeMD Launches Limited-Time 50% Discount on Insulin Resistance Testing to Help Individuals Detect Hidden Health Risks Early here
News-ID: 4063055 • Views: …
More Releases from Binary News Network
BlinkBot Just Solved Crypto's Biggest UX Problem: Trade, Tip, and Predict Market …
Dubai, UAE, 12th December 2025, ZEX PR WIRE, BlinkBot is a new AI-powered trading and transaction assistant on X.com. It removes the friction from on-chain crypto actions, allowing users to manage their portfolios, trade, swap tokens, tip creators and place prediction market bets simply by typing commands directly into a reply or DM.
Actions that once required complex, multi-step processes like opening wallets, switching apps, copying addresses are now compressed into…
Dr. Matthew Hedelius Leads the Way in Trauma-Informed Approaches to Behavioral R …
Logan, Utah, 9th December 2025, ZEX PR WIRE- Dr. Matthew Hedelius, Psy.D., LCSW, CSAT-S, has dedicated more than 26 years to helping people heal from behavioral patterns that impact their well-being and relationships. As the Director and President of Paradise Creek Recovery Center, he hopes to continue treating people who wish to seek lasting recovery with compassion and science-backed methods.
Located on a peaceful 16-acre campus in southern Idaho, Paradise Creek…
Stelios Tzellos Recognized for Contributions to Oncology Market Strategy
London, UK, 11 Dec 2025, ZEX PR WIRE, Stelios Tzellos, Ph.D., continues to be recognized within the pharmaceutical industry for his contributions to oncology market analysis and strategic forecasting. With a formal background in molecular biology and biochemistry from Imperial College London and multiple years of applied experience in healthcare analytics, Tzellos' work has informed commercial planning and strategic evaluation across multiple therapeutic areas, particularly within oncology.
Dr. Tzellos earned his…
Stelios Tzellos Highlights Verified Contributions to Oncology Forecasting and Ev …
London, UK, 11 Dec 2025, ZEX PR WIRE, Stelios Tzellos, Ph.D., is a UK-based molecular biologist and pharmaceutical analyst whose work has contributed to the understanding of both viral gene regulation and oncology market dynamics. With academic roots in biochemistry and molecular biology, and an industry career spanning consulting and analytics roles, Dr. Tzellos has become known for his involvement in evidence-driven oncology strategy.
After earning his Bachelor's and Master's degrees…